-

Tegan Nox returns on NXT

Tegan Nox made her return on NXT last night, her first televised appearance since the September 23 episode of NXT on USA Network.

On that night, Candice LaRae attacked Nox on her injured knee, forcing Nox out of the NXT Women’s championship number one contender’s battle royal match. A week later, WWE announced that Nox suffered her third ACL tear and would be out of action for an undetermined amount of time.

On NXT last night, the battery level that had been appearing on the show for the past few weeks reached 100% during the women’s tag team title match and when the lights came back up, Nox was there, distracting LaRae, which eventually led to The Way’s defeat.

The Welsh star tore her ACL for the first time before the start of the 2017 Mae Young Classic tournament where she was supposed to be a part of. She returned in mid-2018 and was announced for that year’s tournament but she was unlucky again as she tore her ACL, MCL, and suffered other injuries in the quarter final match against Rhea Ripley. This was her third major injury in four years with WWE.

Colin Vassallo
Colin Vassallohttps://www.wrestling-online.com
Colin Vassallo has been editor of Wrestling-Online since 1996. He is born and raised in Malta, follows professional wrestling and MMA, loves to travel, and is a big Apple fan!

Stories you might also likeRELATED
Recommended to you

LATEST NEWS

Royal Rumble 2024 generates $47 million in economic impact for St. Pete area

FOX 13 News in Tampa Bay is reporting that the official report detailing economic impact of the Royal Rumble...

Seth Rollins undergoes surgery for torn meniscus, out for months

While doing media for the current Euro tour, Becky Lynch revealed that her husband Seth Rollins underwent surgery on...

Unveiling Aussie Play Casino’s exciting offers

Welcome to Aussie Play Casino, where every spin of the reel overflows with excitement! As a new player, a...

Discover more from Wrestling-Online.com

Subscribe now to keep reading and get access to the full archive.

Continue reading